Fact CheckerSign in

NCT07729215Completed

Evaluation of the Effects of Systemic Vibration Therapy on Thermogenesis, Cardiovascular Parameters, Endocrine-inflammatory Markers, and Physical-functional Performance in Adults With Obesity.

Source: ClinicalTrials.gov · Last updated 27 Jul 2026

Brief summary (registry, in English)

The goal of this clinical trial was to evaluate the effects of Systemic Vibration Therapy (SVT) on thermogenesis, cardiovascular health, endocrine-inflammatory markers, and physical performance in adults (men and women, aged 18-59) with obesity. The main questions it aimed to answer were: What were the effects of SVT on thermogenesis and physical-functional performance in people with obesity? How did SVT affect cardiovascular risk, hormone levels, and inflammation? Researchers compared two types of vibrating platforms (vertical and side-alternating) to a placebo group (where the platform was turned off but simulated the sound) to see if the vibration led to changes in these health parameters. Participants: Attended sessions 2 times per week for either 6 or 12 weeks. Stood barefoot in a static squat position on a vibrating platform for 29 minutes per session (alternating 1 minute of vibration with 1 minute of rest). Underwent health assessments, including blood tests, body composition scans, muscle strength tests, and quality of life questionnaires.

Status (registry)
Completed
Study type
Interventional
Enrollment
90 (actual)
First submitted
22 Jul 2026
Start date
31 Oct 2024
Primary completion date
31 Jan 2026
Lead sponsor
Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas
Diseases
Obesity
NCT number
NCT07729215

What you commit to

  • Study type: Interventional
  • Participants enrolled: 90
  • From 31 Oct 2024 to the primary completion date, 31 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous diagnosis of deep vein thrombosis;
  • Recent surgery (within the previous 6 months);

Other illness

  • Uncontrolled and untreated hypertension (≥180/120 mmHg);
  • History of labyrinthitis;
  • Neurodegenerative, pulmonary, or infectious diseases;

Other

  • Presence of metallic prostheses;
  • Presence of a pacemaker;
  • Pregnancy;
  • Inability to undergo the proposed assessments and/or interventions.

Who the study is looking for

  • Individuals aged 18 to 59 years;
  • Both sexes;
  • Diagnosis of obesity, defined as a body mass index (BMI) ≥ 30 kg/m²;
  • Waist-to-height ratio (≥ 0.50).

Age in the registry: 18 years to 59 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Laboratório de Vibrações Mecânicas e Práticas Integrativas - Policlínica Universitária Piquet Carneiro
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.